Sample issue
A representative VialWatch Weekly Brief — free for all subscribers. Below is a rendered preview of the actual email format, with sample data drawn from a real recent week of FDA shortage activity.
A voluntary Class II recall on three lots of Piperacillin/Tazobactam 3.375g and 4.5g vials was initiated this week, citing particulate matter. With Pfizer and Sandoz already reporting allocation, this leaves 3 manufacturers with current supply for U.S. hospital systems.
No credit card. Unsubscribe anytime in one click.